Weight Management · Information Only
Semaglutide ODT
Semaglutide ODT is an orally disintegrating tablet formulation of semaglutide — a GLP-1 receptor agonist studied for appetite regulation and metabolic support. The tablet is designed to dissolve on the tongue without water, offering a needle-free alternative to the weekly injection.
Choose Your Plan
Plan pricing and checkout will appear here once pharmacy availability and regulatory eligibility are confirmed.
A Provider-Guided Approach
A Needle-Free Option Under Review
- Explores a needle-free, tongue-dissolving tablet formulation of semaglutide.
- Designed to act on GLP-1 pathways involved in appetite regulation.
- Reviewed by a licensed provider against your full health history.
- Availability and eligibility confirmed only after pharmacy verification.
Clinical research referenced for GLP-1 medications is largely drawn from studies of FDA-approved brand-name injectable products in specific populations with defined BMI eligibility criteria and study durations. Compounded orally disintegrating tablet formulations are not FDA-approved, have not been studied in those trials, and their effectiveness may differ from FDA-approved injectable products; outcomes should not be assumed to be equivalent.
Important medical disclosures
Compounded medications are not FDA-approved, and the FDA does not review them for safety, effectiveness, or quality before marketing. Semaglutide ODT is a compounded orally disintegrating tablet formulation; its effectiveness may differ from FDA-approved injectable semaglutide products, and outcomes should not be assumed to be equivalent. All treatment options on this page remain subject to licensed-provider evaluation, prescription eligibility, pharmacy availability, and applicable regulations. A prescription is issued only when a licensed provider determines treatment is clinically appropriate. This information is not medical advice. Always discuss your full medical history with a licensed provider.